Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
72 hedge funds and large institutions have $23.9M invested in Vicarious Surgical in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 8 reducing their positions, and 22 closing their positions.
225% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 8
0.01% less ownership
Funds ownership: 1.41% → 1.4% (-0.01%)
13% less funds holding
Funds holding: 83 → 72 (-11)
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
42% less capital invested
Capital invested by funds: $41.1M → $23.9M (-$17.2M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAMHA
MY.Alpha Management HK Advisors
Hong Kong
|
+$1.61M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$214K |
| 3 |
Morgan Stanley
New York
|
+$199K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$132K |
| 5 |
BlackRock
New York
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.18M |
| 2 |
HVCM
Hel Ved Capital Management
Central,
Hong Kong
|
-$771K |
| 3 |
ECM
Element Capital Management
New York
|
-$585K |
| 4 |
RP
Regal Partners
Sydney, NSW,
Australia
|
-$390K |
| 5 |
SGM
Seven Grand Managers
Bronxville,
New York
|
-$295K |
RBOT Hedge Fund Activity: Q4 2023 in Review
72 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q4 2023, worth a combined $23.9M — down 42% from $41.1M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of RBOT and 13 opened new positions — a net loss of 9 holders — while 8 trimmed existing stakes and 26 added.
The largest buyer was MY.Alpha Management HK Advisors, adding an estimated $1.61M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $1.18M sold.
- 72 institutional investors held Vicarious Surgical (RBOT) as of Q4 2023, down from 83 in Q3 2023.
- Funds reported $23.9M of Vicarious Surgical stock for Q4 2023, down 42% quarter-over-quarter.
- 13 funds opened new Vicarious Surgical positions in Q4 2023 and 22 closed out, a net change of -9 holders.
- The largest Vicarious Surgical buyer in Q4 2023 was MY.Alpha Management HK Advisors, an estimated $1.61M added.
- The largest Vicarious Surgical seller in Q4 2023 was Alyeska Investment Group, an estimated $1.18M sold.
Based on aggregated 13F filings for Q4 2023.